Based on the results of this study, current recommendations suggest that TNBC patients with tumors larger than 2 cm or with ...

Imlunestrant is being evaluated in patients with ER+/HER2- advanced breast cancer, whose disease progressed on a prior ...

A common hair growth drug could help people who are dealing with hair loss during breast cancer treatment, a study has found.

New data suggests researchers may have found one of their most promising candidates yet for the next generation in ...

An experimental drug stops advanced breast cancer from progressing in some people with tumors that have grown resistant to ...

One expert is working to uncover effective treatments for HER2-positive breast cancer patients by combining different drugs ...

When I discovered a lump on my right breast, aged 40 in 2021, I was in the best health of my life. With a happy marriage, two ...

A recent study conducted by Lund University in Sweden has resolved a long-standing mystery: identifying which patients with ...

The study considered age, race, medical history, cancer details, and other medications. Both physician assessments and ...

The FDA orphan drug designation offers benefits such as tax credits and assistance in the drug development process.

BNT327, now in early-phase trials, is part of a class of drugs that could one day challenge Keytruda’s dominance. BioNTech ...

Experts discussed what other information is needed to understand how best to use Kisqali in treating patients in the adjuvant ...